Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

4.900 +0.050 (+1.03%)
Streaming Delayed Price Updated: 10:35 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aldeyra Therapeu

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
60 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
Aldeyra Therapeutics, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
From Aldeyra Therapeutics, Inc.
Via Business Wire
Why Aldeyra Therapeutics's Stock is Up During Today's Session
Aldeyra Therapeutics's Stock Price And Volume Action Aldeyra Therapeutics (NASDAQ: 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2021 Financial Results and Discuss Recent Business Highlights
From Aldeyra Therapeutics, Inc.
Via Business Wire
Why Aldeyra Therapeutics Stock Is Sinking Today
The company plans to conduct a public stock offering. 
Via The Motley Fool
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
Via Benzinga
Aldeyra Seeks To Raise $125M Via Equity To Support Reproxalap US Application
Aldeyra Therapeutics Inc (NASDAQ: ALDX) intends to sell $125 million shares of its common stock in an underwritten public offering. Underwriters will... 
Via Benzinga
Aldeyra Therapeutics, Inc. Announces Proposed $125 Million Public Offering of Common Stock
From Aldeyra Therapeutics, Inc.
Via Business Wire
52 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (... 
Via Benzinga
Mid-Afternoon Market Update: TrueBlue Rises Following Q1 Earnings; RealNetworks Shares Slide
Toward the end of trading Tuesday, the Dow traded down 0.02% to 33,975.58 while the NASDAQ fell 0.34% to 14,090.03. The S&P also fell, dropping 0.05% to 4,185.36. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; PQ Group Shares Plummet
Midway through trading Tuesday, the Dow traded down 0.08% to 33,955.78 while the NASDAQ fell 0.30% to 14,096.16. The S&P also fell, dropping 0.09% to 4,183.81. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1... 
Via Benzinga
Why Aldeyra Therapeutics Stock Is Soaring Today
The company reported great clinical results for its lead pipeline candidate. 
Via The Motley Fool
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Apr. 27, 2021: UPS, ALDX, FISV, PFPT, GOOG
Today's 5 Stock Ideas: United Postal Service (UPS) - Shares were up roughly 8% Tuesday morning. The company reported better-than-expected Q1 EPS and sales results... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8... 
Via Benzinga
Aldeyra Therapeutics Stock Is Trading Higher On Acing Allergic Conjunctivitis Study With Reproxalap
Aldeyra Therapeutics Inc (NASDAQ: ALDX) has announced positive top-line results from the Phase 3 INVIGORATE trial evaluating 0.25% reproxalap, in... 
Via Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) shares rose 29.1% to $1.20 in pre-market trading. RiceBran Technologies is scheduled to host a conference call on April 28th to... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis
From Aldeyra Therapeutics, Inc.
Via Business Wire
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 INVIGORATE Clinical Trial
From Aldeyra Therapeutics, Inc.
Via Business Wire
44 Biggest Movers From Yesterday
Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.